- Home
- RAVE vs KPTI Comparison
RAVE vs KPTI Comparison
Compare RAVE & KPTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RAVE | KPTI |
|---|---|---|
| Founded | 1958 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Restaurants | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 41.4M | 36.7M |
| IPO Year | 1995 | 2013 |
Fundamental Metrics
Financial Performance| Metric | RAVE | KPTI |
|---|---|---|
| Price | $2.14 | $0.66 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $7.25 |
| AVG Volume (30 Days) | 34.6K | ★ 4.0M |
| Earning Date | 11-13-2026 | 11-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 5.26 | N/A |
| EPS | ★ 0.20 | N/A |
| Revenue | $15,120,000.00 | ★ $146,067,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $27.98 |
| P/E Ratio | $10.98 | ★ N/A |
| Revenue Growth | N/A | ★ 0.57 |
| 52 Week Low | $2.06 | $0.31 |
| 52 Week High | $3.60 | $10.99 |
Technical Indicators
Market Signals| Indicator | RAVE | KPTI |
|---|---|---|
| Relative Strength Index (RSI) | 33.21 | 43.07 |
| Support Level | $2.09 | $0.31 |
| Resistance Level | $3.43 | $2.16 |
| Average True Range (ATR) | 0.10 | 0.13 |
| MACD | 0.02 | 0.10 |
| Stochastic Oscillator | 0.00 | 52.93 |
Price Performance
Historical ComparisonAbout RAVE Rave Restaurant Group Inc.
Rave Restaurant Group Inc operates and franchises pizza buffet, delivery/carry-out, express restaurants, and ghost kitchens. It operates restaurants under the brand name, Pizza Inn, and Pie Five Pizza Company. It has three operating segments. The Pizza Inn Franchising and Pie Five Franchising segments establish franchisees, licensees, and territorial rights. The corporate administration and other segments. The Pizza Inn Franchising segment accounts for the majority of the company's revenue. Geographically, it generates the majority of the revenue from the United States.
About KPTI Karyopharm Therapeutics Inc.
Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company focused on novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. The company conducts research focused on intracellular communication between the nucleus and cytoplasm and has developed small-molecule compounds that inhibit exportin 1 (XPO1), a nuclear export protein. It is focused on marketing XPOVIO (selinexor).